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ABSTRACT 
Poultry products (meat and eggs) are a major source of animal protein on which the world is 
increasingly reliant to feed a rapidly growing population. Improved breeds and advances in 
farm management practices have had a large impact on the poultry industry. For example, 
using current genetic stock and production practices, broiler chickens can weigh 2 kg in 
about 34 days. Forty-five years ago it would have typically taken over 60 days. These 
impressive advances have been made using traditional selective breeding methods and 
more recently by using genomics. Now, with the availability of precision genome 
engineering tools there are new opportunities to improve poultry production above and 
beyond those achievable by traditional means. One major opportunity is disease resilience, 
particularly for viral diseases such as avian influenza that has devastating impacts on the 
poultry industry. Resilience to specific diseases can be a notoriously difficult trait to select 
for using traditional breeding and the latest technologies that precisely edit the genome 
have created new ways to address this challenge.  
 
INTRODUCTION 
Precision genome engineering (PGE) tools for rapid and specifically directed change of 
poultry genomes have created a new approach for the precision breeding of poultry for 
food production. It is now possible to introduce intra- or inter-species single nucleotide 
polymorphisms (SNPs) into a chicken line for improved productivity. SNPs and larger 
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changes in genetic loci occur spontaneously within individuals in a species and become 
prevalent or dominant in that species if they confer an advantage through the selective 
pressures the species is experiencing. With the advent of genetics, molecular biology and 
genome sequencing it has been possible to apply SNP screening to locate and select for 
desirable production and disease resistance traits in a range of livestock species. This has 
enabled a rapid improvement in the development of elite genetics for many species 
including poultry but in particular the chicken. This still requires a steady and iterative 
process of breeding, screening and selection.  The new era that is ushered in by these new 
PGE tools means that desirable SNPs, or the gene variants associated with them, can be 
introduced into a line of genetics in a single step rather than taking several reproductive 
rounds including screening.  This could be the beginning of a new agricultural revolution 
dramatically reducing the time taken to improve lines of chicken for particular production 
environments and to introduce resilience to specific diseases that may threaten the security 
of the food production system. If these SNPs or variants already exist within the species and 
could be introduced with a longer time frame by conventional breeding, we foresee reduced 
complexity for regulatory approval of these technologies and their outcomes when 
compared to more traditional genetic engineering approaches.  This should, if 
communicated clearly and effectively, also challenge the traditional public perception of 
genetic modification as the new technology delivers precision breeding of intra-species 
traits compared with the random integration of exogenous genes or traits.  
 
THE CHALLENGE FOR PRECISION GENOME ENGINEERING IN BIRDS 
In many animals to date, PGE components for TALEN and CRISPR (DNA, RNA or protein) 
have been directly injected into the zygote where they target the genome and result in 
animals carrying edits on one or both chromosomes (1, 2). For improved precision over this 
process, targeting in somatic cells such as fibroblasts can be used to produce edits, followed 
by somatic cell nuclear transfer to produce live progeny carrying the mutations (3-5). This 
has already proven to be very efficient and highly precise and has considerably expanded 
scientists’ ability to make specific alterations to the genomes of a variety of animals. 
4 
 
   
National Institutes of Bioscience Journal 2016, Vol. 1    
http://www.nibjournal.ed.ac.uk/   http://dx.doi.org/10.2218/natlinstbiosci.1.2016.1742 
 
However, due to differences in reproductive physiology and structure of the fertilised egg 
and early embryo, many of the relatively straightforward procedures that are used to 
generate gene-edited fish and mammals are not applicable in avian species. This is because 
the avian ovum forms with a vitelline membrane which becomes a protective sac around 
the swelling yolk until it is released and fertilised in the infundibulum at the top of the 
oviduct. The single-cell zygote is therefore intimately linked with the yolk and subsequently 
very difficult to manipulate. While recent advances have been made in the areas of avian 
ova culture and in vitro intracytoplasmic sperm injection (6), these techniques are as yet too 
demanding to consider using for genome editing. Nevertheless, multiple very effective 
methods have been established for engineering the germline of birds and these are now 
successfully being developed for gene editing and will lead to rapid advances in the 
technology in poultry.  
 
METHODS FOR APPLYING GENE EDITING TOOLS IN POULTRY SPECIES 
In mammalian species common methods for production of transgenic and gene-edited 
animals include modification and transplantation of embryonic stem (ES) cells to early 
blastocysts (7-9), modification of somatic cells in culture for somatic cell nuclear transfer 
(10-12), or direct delivery of transgenes or gene editing components to in vitro fertilised 
zygotes (13-15). In birds, while early work was done with ES cells (16) the reproductive 
physiology of avian species greatly restricts access to the ovum or the early blastocyst, thus 
the methods used in mammals are not used in birds.  Generation of transgenic chickens, and 
later gene-edited chickens has been facilitated by the development of methods to establish 
primordial germ cell (PGC) cultures.  Early in embryogenesis PGCs migrate from the germinal 
crescent into the bloodstream until they reach the genital ridges, colonise the developing 
gonads and differentiate into germ cells (reviewed in 17), making them a suitable cell type 
for genetic modification of the germ line.  
Early work with avian PGCs demonstrated that chimeric chickens could be produced by 
isolating PGCs from donor chickens and directly transferring them into recipient embryos 
(18) or culturing the PGCs for a short time, then transferring them (19). In 2006 a major 
breakthrough was made when Van de Lavoir et al. (20) demonstrated that chicken PGCs can 
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be isolated, cultured long term and genetically modified while maintaining their 
commitment to the germ line. The modified PGCs were transferred to recipient embryos, 
successfully generating germline chimeras, and breeding of the germline chimeras resulted 
in transgenic chicks. Since 2006 many different lines of transgenic chickens have been 
produced through PGC culture (21-24). In addition, a number of techniques which use PGC 
culture have been employed to generate gene-knockout chickens including homologous 
recombination (25), TALENS (26) and the CRISPR/Cas 9 system (27,28).  
Another recent advancement in PGC technology is the ability to genetically modify PGCs in 
vivo (29). This method involves complexing a plasmid containing a transgene flanked by 
transposon recognition sites and a plasmid containing the transposase gene with a 
transfection reagent. The complexed plasmids are then directly injected into the 
bloodstream of early embryos, transfecting the migrating PGCs on route to the developing 
gonads. In a portion of the transfected PGCs the transposase will induce transgene 
integration into the genome. The direct injection method also holds promise for delivery of 
gene editing components such as TALENs and CRISPR/Cas, however to date no work has 
been published validating this.  
Lack of access to ovum or single celled embryos has in part driven the development of these 
PGC-based methods. However recent advances have been made in the areas of avian ova 
recovery, culture and in vitro intracytoplasmic sperm injection (6). Researchers were able to 
recover ova from quail, fertilise them by intracytoplasmic sperm injection, culture the 
resulting embryos for a day and then transfer the fertilised embryos to surrogate shells, 
where they lived for up to two additional days. These advances indicate that direct 
manipulation of avian ovum and single-cell embryos may one day be used for genome 
editing applications.  
Unlike the ovum, avian sperm can easily be collected. However it is difficult to maintain 
sperm viability once it is collected, making direct genetic manipulation of the sperm genome 
difficult. Previous research shows that sperm can be efficiently transfected (30) and gene 
editing tools like TALENs and CRISPR/Cas9 can be used to transfect sperm that can then be 
delivered during fertilization for editing the single-cell zygote. This process is known as 
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sperm transfection assisted gene editing, or STAGE, and has been used recently to make 
gene knockout chickens (31). Being able to use sperm for the generation of gene knockouts 
opens up this technology to species where PGC culture methods do not exist.  
DISEASE RESILIENCE  
Disease outbreaks in poultry pose a significant risk to the commercial poultry industry 
causing devastating loss to the economies of developed and developing countries. Avian 
Influenza Virus (AIV) is one such destructive and economically important poultry disease due 
its ability to rapidly re-assort and become hypervirulent causing sporadic pandemic events, 
often with a high mortality rate (32, 33). Current vaccination strategies using live or 
inactivated viral vaccine strains to control AIV in poultry is either limited or ineffective as the 
efficacy is complicated by factors such as age of the bird, health status and antigenic 
distance of infected virus (34). Therefore, development of feasible and sustainable long-
term methods to control emerging pathogens is desirable, and has been a long-standing 
goal.  
Breeding for disease resistance is a very challenging task within the poultry industry. 
Although genetic variance is one of the major determinants to confer resistance, the 
practical applications in poultry are yet to be discovered. The rapid progression of genomic 
resources and next-generation sequencing can allow us to analyse genetic, epigenetic, 
transcriptomic variations within the species or related species to determine the factors 
associated with susceptibility and resistance to disease. For instance, the fayoumi chicken is 
renowned to have resistance against infectious diseases (35). A recent study has identified 
differential gene expression patterns to AIV infection in two distinct genetic lines of chicken 
species; the fayoumi and Leghorn chickens. Further investigations on these differentially 
expressed genes and introduction of those salient genomic variations to the chicken 
genome using gene editing technology can provide new insights into the production of 
disease-resistant chickens. 
The recent findings of a species-specific host co-factor polymerase activity of avian influenza 
viruses, the chicken ANP32A (chANP32A) protein, is an intriguing example for understanding 
disease mechanisms. Although ANP32A is present in humans (huANP32A), the presence of 
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an additional ~ 33 amino acid insert in chicken ANP32A was shown to be a key contributing 
factor for the enhanced avian polymerase activity in avian cells (36). Using gene editing 
technology, substituting the chANP32A gene with huANP32A could impair the enhanced 
polymerase activity of avian influenza virus in chicken cells, thereby providing resistance to 
chickens against influenza.   
Another clear opportunity to gain insight and potentially identify gene editing targets for 
disease resilience is via comparative genomics of chickens and ducks. Despite being a closely 
related species to chicken, the duck possesses very distinctive innate immune responses and 
resistance to AIV infection (37, 38). The absence of the RIG-I gene in chickens compared 
with ducks was demonstrated to confer relative susceptibility of chickens to AIV infection 
(34). The utilisation of genome editing technology in this context, to precisely introduce 
these RIG-I or RIG-I-like “natural” disease-resistance genes into safe harbor locations in the 
chicken genome can open the possibility of breeding chickens with increased resistance to 
influenza.    
  
NEXT-GENERATION OF VACCINE EGGS 
Another area in which the genome editing of poultry has the potential for real impact is the 
production of specialised eggs for vaccine manufacture. Embryonated chicken eggs are used 
to grow a number of vaccines for both humans and animals. The most common of these is 
influenza vaccine which has been grown in embryonated chicken eggs since its introduction 
in the 1940s. Other than advancements in automation and purification, the process to grow 
influenza in eggs has changed very little over this time and it is known that the growth of the 
vaccine is limited by the embryo. In some cases up to two eggs can be required for a single 
dose of influenza vaccine. This means that major vaccine companies can use greater than 1 
million eggs per day to meet the requirement for vaccine production.  
We now have the ability to not only identify the genes which restrict virus growth using 
either siRNA or CRISPR whole-genome screens in vitro, but we can also edit these genes in 
the genome of the chicken to produce eggs that could produce higher yields of virus for 
vaccine production. The ability to produce high vaccine yield eggs would have implications 
8 
 
   
National Institutes of Bioscience Journal 2016, Vol. 1    
http://www.nibjournal.ed.ac.uk/   http://dx.doi.org/10.2218/natlinstbiosci.1.2016.1742 
 
for the whole vaccine production chain. The ability to reduce the amount of eggs required 
would reduce transport costs as well as the cost of waste disposal, which can be large as all 
waste produced from influenza vaccine manufacturing is biological waste that contains live 
infectious virus.  
In addition to reducing the number of eggs needed for influenza vaccine production it may 
also be possible to improve the eggs in other ways. For some serotypes of influenza their 
growth in eggs can alter the composition of their haemagglutinin meaning the virus grown 
in the eggs no longer protects effectively against the wild-type virus. Much like the 
identification of pro-viral genes, if we are able to identify those responsible for causing the 
alterations in haemagglutinin we would be able to modify them. These eggs would be 
capable of growing virus which is more representative of the wild-type virus used to 
inoculate them and would therefore provide better protection. 
Another option is to modify eggs to allow the growth of other viruses which otherwise do 
not grow well in eggs. Using a whole-genome screen in the same way as described for 
influenza, genes that inhibit the growth of these viruses could be identified. The chicken 
genome could then be altered to produce eggs that allow the growth of these virus. This 
approach could be useful for viruses that are currently difficult to produce vaccines for due 
to low virus yields. There is also the potential for these eggs which grow other viruses to be 
processed in the existing infrastructure at influenza vaccine manufacturing plants.  
 
SELECTIVELY HATCHING FEMALE CHICKS 
Genetics has contributed to our understanding of the domestication of poultry, likely more 
than 8,000 thousand years ago (39). It has also contributed to the high performance of the 
two major type of birds, broilers and layers, used to generate meat and eggs respectively. 
The dramatic difference in the metabolism of these two types means that male birds 
generated in the layer industry are no longer commercially viable to grow out for meat in 
most commercial settings. As a result males are identified following hatch, by manual sexing 
or feather colour identification, and immediately euthanised with a low value recovery of 
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nutrient from their carcasses. This practice is fraught with ethical issues and incurs costs and 
production value loss to farmers.  
There is a clear need in industry for an alternative that can either identify male chicks before 
they hatch, preferably at point of lay. The United Egg Producers in the USA have made a 
statement that they will aim to remove the practice of male culling by 2020 
(http://uepcertified.com/united-egg-producers-statement-eliminating-male-chick-culling/).  
There has been a long history of study into the processes of sexual differentiation during 
development and into the genes and processes involved (40). While this process is well 
understood, the key male determining trigger has not yet been proven beyond doubt (41). 
Other than addition of exogenous hormone (a practice that would not be acceptable to 
industry or to the consumer) there is little that can be done by way of intervention. 
Therefore, attention has turned to methods to identify male embryos.  
The advent of precision gene editing techniques presents the opportunity to place specific 
marker genes on the male sex determining chromosome, the Z chromosome. In chicken, 
and birds in general, the female is the heterogametic sex, carrying one Z and one W 
chromosome, thus ZW. The male is homogametic, being ZZ, and best evidence indicates 
that a double dose of the gene DMRT1 on the Z chromosome is key in male development (in 
the absence of current evidence of a W specific female determining gene). If a marker gene 
can be site specifically engineered into a safe location on the Z chromosome (Z*) then a 
breeding pair Z*W (female) crossed with ZZ (male) would yield the following offspring: ZW 
(f), Z*Z (m), ZZ* (m), ZW (f). So a marker gene on the Z chromosome of a female when 
crossed to a wild-type male will always yield males carrying the marker gene and females 
free of the marker gene. This is a null-segregation technique commonly used in plant 
breeding systems. In a most simplistic set-up the marker gene could be a constitutively 
expressed green fluorescent protein, such that male embryos even at the point of lay when 
the embryo is only 60,000 mostly undifferentiated cells, it would be green. Current 
indications are that with appropriate lasers and detectors this could be detected through 
the shell of a freshly laid egg without the need for invasive sampling. Since eggs are 
routinely “candled” to check for viability based on the visualization of venous networks 
through the shell, a form of light based detection should be able to be adapted to detect the 
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marker on the males. There are many alternative genes that could be used to provide other 
means of detection of the mark and the male. The power of this technique is to combine the 
selectable transgene with the null-segregant exclusion process widely accepted in plant 
food production (42). This generates wild-type females yielding eggs for the consumer – 
with the added value of no-“hatch-and-cull” improved production ethics. The farmer also 
benefits from reduced incubation, egg handling and easier nutrient recovery from males.  
 
INCREASED FOOD SAFETY 
Gene editing can be used to improve the food safety of poultry products, namely by 
removing the allergenic components of chicken eggs. Allergy to chicken egg is a widespread 
condition affecting up to 2.5% of children and is the second most common food allergy. This 
presents a major food safety issue for the community since eggs are used in such a wide 
range of food products. Furthermore, the widespread use of egg-based flu vaccines poses 
additional risks. The incidence of egg allergy in many parts of the world is increasing and the 
cause of this is not understood and subject to much debate.  
Egg allergy is caused by 4 proteins within the egg white: ovomucoid (Ovm), ovalbumin (Ova), 
ovotransferrin and lysozyme (43). Ovm is the most allergenic of the four proteins and as 
such is not surprisingly the first of the allergens to be targeted for gene editing (28). A large 
amount of research has been carried out to characterise the function of the various egg 
white proteins, however no clear role has been identified for Ovm in fertility, egg formation 
or nutritional value. Even though Ovm is the most allergenic egg white protein, it only 
makes up a small amount of the total egg white protein (~10% compared to Ova which is 
>50%). The absence of a clear or critical function for Ovm in conjunction with its low 
abundance may allow for the successful targeted deletion of the Ovm gene in layer hens. 
Oishi et al. (28) have made excellent progress to demonstrate this and have reported the 
successful generation of a homozygous Omv knockout female chick using CRISPR. We are all 
now waiting for this bird to reach egg laying age and for a future publication detailing the 
impact of this gene deletion on Ovm allergenicity, reproductive viability of the hen and 
physical properties of egg white with respect to processing, cooking and taste.  
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It will not be possible to delete the genes encoding the remaining 3 allergens (Ova, 
ovotransferrin and lysozyme). The function of these proteins are well understood and all are 
critical for the development of an embryo within the egg. The allergenic epitopes within 
these 3 proteins have been characterised and compared with other avian species including 
related galliformes and the more distantly related emu (44). Based on this research it may 
be possible to specifically edit key amino acid sequences within these epitopes to develop 
hypoallergenic versions of these key genes whilst retaining the critical functionality of each 
protein. This precise editing is now made possible with PGE tools such as TALEN and CRISPR 
and opens the possibility of producing allergen-free eggs to eliminate the serious food 
safety issues associated with egg allergy and to also improve the safety of vaccines that are 
grown in chicken eggs.  
 
CONCLUSION – IMPACTS FOR THE POULTRY INDUSTRY  
The application of PGE in animal agriculture has great potential with many experts 
predicting that this technology is game-changing with respect to breeding of desired traits in 
livestock species. It enables the rapid introduction of beneficial, naturally occurring 
mutations that already exist within a species or closely related species into elite breeding 
animals. It is precise and does not introduce deleterious or unwanted traits that arise via 
traditional selective breeding. We now have the technology to create precise, targeted 
modifications to the chicken genome. The impacts of this can lead to improved efficiency 
and sustainability of poultry production to help meet the challenges associated with global 
food security. Specific innovations that result from gene editing technology will lead to new 
approaches for managing disease, improving welfare, increasing food safety and enhancing 
the production and safety of vaccines that are grown in chicken eggs.  It is possible that the 
latest developments in gene editing technology may help to reduce or remove the two 
major barriers to the acceptance and application of genetic engineering technology in 
animal agriculture: regulatory approval and public perception. This could pave the way for 
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gene editing and precision breeding to impact on the safe, secure and sustainable 
production of poultry protein.  
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